Total Payments
$1,202
2024 Payments
$359.65
Companies
18
Transactions
84
Medicare Patients
1,690
Medicare Billing
$74,588
Payment Breakdown by Category
Food & Beverage$1,202 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,202 | 84 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $280.16 | 28 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $176.43 | 13 | $0 (2023) |
| Mylan Specialty L.P. | $135.03 | 8 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $125.14 | 5 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $113.75 | 5 | $0 (2024) |
| Lilly USA, LLC | $95.39 | 7 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $49.75 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $44.40 | 3 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $32.38 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $21.05 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $359.65 | 17 | Neurocrine Biosciences, Inc. ($113.75) |
| 2023 | $145.15 | 9 | Otsuka America Pharmaceutical, Inc. ($29.28) |
| 2022 | $250.37 | 18 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($120.37) |
| 2021 | $446.38 | 40 | Sunovion Pharmaceuticals Inc. ($280.16) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/13/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: DIABETES | ||||||
| 10/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Neuropsychiatry | ||||||
| 09/11/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Central Nervous System | ||||||
| 08/14/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Neuroscience | ||||||
| 07/31/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: SCHIZOPHRENIA | ||||||
| 07/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Neuropsychiatry | ||||||
| 07/24/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: SCHIZOPHRENIA | ||||||
| 06/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Neuropsychiatry | ||||||
| 05/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Neuropsychiatry | ||||||
| 04/25/2024 | TREACE MEDICAL CONCEPTS, INC. | LAPIPLASTY SYSTEM (Device) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: FOOT AND ANKLE | ||||||
| 04/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Neuropsychiatry | ||||||
| 03/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Central Nervous System | ||||||
| 02/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: PSYCHIATRY | ||||||
| 01/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: DIABETES | ||||||
| 10/25/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/06/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: ETONOGESTREL | ||||||
| 05/03/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 04/19/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Diabetes | ||||||
| 02/23/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Diabetes | ||||||
| 01/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 452 | 839 | $60,512 | $23,563 |
| 2022 | 9 | 294 | 594 | $41,006 | $15,874 |
| 2021 | 14 | 473 | 808 | $49,794 | $20,630 |
| 2020 | 12 | 471 | 804 | $43,059 | $14,520 |
Total Patients
1,690
Total Services
3,045
Medicare Billing
$74,588
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 239 | $36,687 | $15,602 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 120 | $12,480 | $4,370 | 35.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 19 | 22 | $2,365 | $1,026 | 43.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 67 | 101 | $1,111 | $841.68 | 75.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 47 | 61 | $2,440 | $789.83 | 32.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 40 | 50 | $1,850 | $468.38 | 25.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 33 | 45 | $1,575 | $277.29 | 17.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 12 | 12 | $264.00 | $62.50 | 23.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 19 | $266.00 | $41.80 | 15.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 19 | 108 | $1,080 | $40.45 | 3.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 12 | 14 | $154.00 | $39.82 | 25.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 12 | 48 | $240.00 | $3.88 | 1.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 105 | 306 | $31,824 | $12,991 | 40.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 14 | $2,149 | $910.81 | 42.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 12 | 14 | $1,505 | $656.74 | 43.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 34 | 41 | $1,640 | $529.94 | 32.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 22 | 28 | $1,036 | $260.55 | 25.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 53 | 83 | $913.00 | $245.49 | 26.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 23 | 31 | $1,085 | $216.06 | 19.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 19 | 21 | $294.00 | $44.92 | 15.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 13 | 56 | $560.00 | $18.66 | 3.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 121 | 226 | $23,504 | $11,385 | 48.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 112 | $17,192 | $7,042 | 41.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 12 | 13 | $1,398 | $667.03 | 47.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 27 | 31 | $1,240 | $415.09 | 33.5% |
About Adrian Unger, APRN
Adrian Unger, APRN is a Family healthcare provider based in Tahlequah, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2018. The National Provider Identifier (NPI) number assigned to this provider is 1396210514.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Adrian Unger, APRN has received a total of $1,202 in payments from pharmaceutical and medical device companies, with $359.65 received in 2024. These payments were reported across 84 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,202).
As a Medicare-enrolled provider, Unger has provided services to 1,690 Medicare beneficiaries, totaling 3,045 services with total Medicare billing of $74,588. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Tahlequah, OK
- Active Since 10/04/2018
- Last Updated 02/04/2026
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1396210514
Products in Payments
- XIFAXAN (Drug) $176.43
- APTIOM (Drug) $148.32
- INGREZZA (Drug) $113.75
- Yupelri (Drug) $112.87
- LONHALA MAGNAIR (Drug) $106.71
- FANAPT (Drug) $102.27
- TRULICITY (Drug) $52.34
- REXULTI (Drug) $49.75
- Austedo XR (Drug) $32.38
- JARDIANCE (Drug) $29.91
- EMGALITY (Drug) $27.99
- GEMTESA (Drug) $25.13
- HETLIOZ (Drug) $22.87
- YUPELRI (Drug) $22.16
- TRELEGY ELLIPTA (Drug) $21.05
- LAPIPLASTY SYSTEM (Device) $20.58
- QUTENZA (Drug) $20.52
- INVEGA SUSTENNA (Drug) $19.77
- NEXPLANON (Drug) $16.08
- BASAGLAR (Drug) $15.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Tahlequah
Leslie Davenport, Aprn, APRN
Family — Payments: $1,162
Family $1,162
Stephanie Lecrone, Aprn, APRN
Family — Payments: $939.62
Family $939.62
Ragan Birckel, Fnp-C, FNP-C
Family — Payments: $343.22
Family $343.22
Florame Jamison, Aprn, APRN
Family — Payments: $333.89
Family $333.89
Jo-Anna Coppin, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $273.30
Family $273.30
Mrs. Madyson Snow, Aprn-Cnp, APRN-CNP
Family — Payments: $224.85
Family $224.85